Quetiapine augmentation of prolonged exposure therapy in veterans with PTSD and a history of mild traumatic brain injury: design and methodology of a pilot study
Abstract Background Selective serotonergic reuptake inhibitors (SSRIs) are first-line pharmacologic treatments for patients with posttraumatic stress disorder (PTSD), but must be given over extended period of time before the onset of action. The use of SSRIs in PTSD patients with mild traumatic brai...
Main Authors: | Muhammad R. Baig, Robert D. Beck, Jennifer L. Wilson, Jennifer A. Lemmer, Adeel Meraj, Eric C. Meyer, Jim Mintz, Alan L. Peterson, John D. Roache |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-10-01
|
Series: | Military Medical Research |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s40779-020-00278-0 |
Similar Items
-
Sexual Dysfunctions among Veterans with and without PTSD
by: Marina Protuđer, et al.
Published: (2023-06-01) -
Quetiapine: recent developments in preclinical research
by: Marco Orsetti, et al.
Published: (2010-03-01) -
Overdose of Quetiapine—A Case Report with QT Prolongation
by: Elisabetta Bertol, et al.
Published: (2021-12-01) -
Latino Veterans with PTSD: A Systematic Review
by: James O. E. Pittman
Published: (2014-09-01) -
Quetiapine Addiction: A Case Report
by: A. Chaara, et al.
Published: (2022-06-01)